Michael A. Kelly's Insider Trades & SAST Disclosures
Michael A. Kelly's most recent trade in DMC Global Inc was a trade of 5,518 Common Stock done . Disclosure was reported to the exchange on Feb. 26, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael A. Kelly.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 5,518 | 31,073 (0%) | 0% | 0 | Common Stock | |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 182 | 182 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 71 | 120 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Herc Holdings Inc | Michael A. Kelly | Director | Sale of securities on an exchange or to another person at price $ 208.83 per share. | 24 Oct 2024 | 3,880 | 13,774 (0%) | 0% | 208.8 | 810,260 | Common Stock |
| Neogenomics Inc. | Michael A. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2024 | 11,336 | 0 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Michael A. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2024 | 11,336 | 31,755 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 12,254 | 12,254 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 8,672 | 8,672 | - | - | Stock Option (Right to Buy) | |
| Herc Holdings Inc | Michael A. Kelly | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2024 | 9,399 | 17,654 (0%) | 0% | 0 | Common Stock | |
| Herc Holdings Inc | Michael A. Kelly | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2024 | 9,399 | 834 (0%) | 0% | 0 | Common Stock | |
| Herc Holdings Inc | Michael A. Kelly | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2024 | 8,255 | 8,255 (0%) | 0% | 0 | Common Stock | |
| Herc Holdings Inc | Michael A. Kelly | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2024 | 8,255 | 10,233 (0%) | 0% | 0 | Common Stock | |
| Herc Holdings Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 834 | 18,488 (0%) | 0% | 0 | Common Stock | |
| DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 9,520 | 25,555 (0%) | 0% | 0 | Common Stock | |
| Mettler-Toledo Internation... | Kelly A. Michael | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 1,268 | 0 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo Internation... | A. Kelly Michael | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 263.62 per share. | 12 Feb 2024 | 1,268 | 2,945 (0%) | 0% | 263.6 | 334,270 | Common Stock, par value $0.01 per share |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Sale of securities on an exchange or to another person at price $ 1175.74 per share. | 12 Feb 2024 | 400 | 2,018 (0%) | 0% | 1175.7 | 470,296 | Common Stock, par value $0.01 per share |
| Mettler-Toledo Internation... | Michael Kelly A. | Director | Sale of securities on an exchange or to another person at price $ 1178.16 per share. | 12 Feb 2024 | 341 | 1,677 (0%) | 0% | 1178.2 | 401,753 | Common Stock, par value $0.01 per share |
| Mettler-Toledo Internation... | Kelly A. Michael | Director | Sale of securities on an exchange or to another person at price $ 1174.68 per share. | 12 Feb 2024 | 227 | 2,418 (0%) | 0% | 1174.7 | 266,652 | Common Stock, par value $0.01 per share |
| Mettler-Toledo Internation... | A. Kelly Michael | Director | Sale of securities on an exchange or to another person at price $ 1170.32 per share. | 12 Feb 2024 | 200 | 2,745 (0%) | 0% | 1170.3 | 234,064 | Common Stock, par value $0.01 per share |
| Mettler-Toledo Internation... | A. Kelly Michael | Director | Sale of securities on an exchange or to another person at price $ 1171.31 per share. | 12 Feb 2024 | 100 | 2,645 (0%) | 0% | 1171.3 | 117,131 | Common Stock, par value $0.01 per share |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 250 | 250 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 49 | 1,677 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 11,336 | 11,336 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 8,353 | 8,353 | - | - | Stock Option (Right to Buy) | |
| Herc Holdings Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 1,301 | 17,654 (0%) | 0% | 0 | Common Stock | |
| DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 7,086 | 16,035 (0%) | 0% | 0 | Common Stock | |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 244.99 per share. | 08 Nov 2022 | 1,484 | 3,112 (0%) | 0% | 245.0 | 363,565 | Common Stock, par value $0.01 per share |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 1,484 | 0 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Sale of securities on an exchange or to another person at price $ 1357.65 per share. | 08 Nov 2022 | 784 | 1,628 (0%) | 0% | 1357.7 | 1,064,398 | Common Stock, par value $0.01 per share |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Sale of securities on an exchange or to another person at price $ 1354.92 per share. | 08 Nov 2022 | 700 | 2,412 (0%) | 0% | 1354.9 | 948,444 | Common Stock, par value $0.01 per share |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 224 | 224 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 41 | 1,628 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,556 | 20,419 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 13,882 | 13,882 | - | - | Stock Option (Right to Buy) | |
| Herc Holdings Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 1,101 | 16,353 (0%) | 0% | 0 | Common Stock | |
| DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 5,006 | 8,949 (0%) | 0% | 0 | Common Stock | |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 222 | 222 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 30 | 1,587 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Aprea Therapeutics Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 22,750 | 22,750 | - | - | Stock Option (Right to Buy) | |
| Aprea Therapeutics Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 4,610 | 4,610 (0%) | 0% | 0 | Common Stock | |
| Herc Holdings Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 1,034 | 15,252 (0%) | 0% | 0 | Common Stock | |
| DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 1,888 | 3,943 (0%) | 0% | 0 | Common Stock | |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2020 | 316 | 316 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2020 | 41 | 1,557 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Hookipa Pharma Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2020 | 5,754 | 5,754 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2020 | 12,000 | 12,000 | - | - | Stock Option (right to Buy) | |
| Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 2,223 | 2,223 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 1,782 | 1,782 (0%) | 0% | 0 | Common Stock | |
| DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2020 | 2,055 | 2,055 (0%) | 0% | 0 | Common Stock | |
| Hookipa Pharma Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 9,600 | 9,600 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges